Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accounts Payables (2018 - 2025)

Dna X's Accounts Payables history spans 8 years, with the latest figure at $4.0 million for Q4 2025.

  • Quarterly results put Accounts Payables at $4.0 million for Q4 2025, up 446.07% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (up 446.07% YoY), and the annual figure for FY2025 was $4.0 million, up 446.07%.
  • Accounts Payables for Q4 2025 was $4.0 million at Dna X, down from $20.4 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $23.3 million in Q3 2023 to a low of $738000.0 in Q4 2024.
  • The 5-year median for Accounts Payables is $13.0 million (2021), against an average of $14.0 million.
  • The sharpest move saw Accounts Payables tumbled 96.28% in 2024, then soared 446.07% in 2025.
  • Year by year, Accounts Payables stood at $9.5 million in 2021, then skyrocketed by 123.01% to $21.1 million in 2022, then dropped by 6.05% to $19.8 million in 2023, then tumbled by 96.28% to $738000.0 in 2024, then soared by 446.07% to $4.0 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $4.0 million, $20.4 million, and $20.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.